XML 30 R20.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
FAIR VALUE MEASUREMENT (Tables)
3 Months Ended
Mar. 31, 2024
Investments, All Other Investments [Abstract]  
SCHEDULE OF FAIR VALUE VALUATION ASSUMPTIONS

   February 8, 2024 
Risk free interest rate   4.20 - 4.28%
Expected term (years)   2.75 - 2.76 
Expected volatility   102%
Expected dividends   0.00%

 

The following table shows the detail of the valuation assumptions used:

 

   February 8, 2024 
Risk free interest rate   4.12%
Expected term (years)   5.00 
Expected volatility   101%
Expected dividends   0.00%

 

 

   March 31, 2024 
Risk free interest rate   4.21 - 4.22%
Expected term (years)   2.61 - 4.86 
Expected volatility   101%
Expected dividends   0.00%
 
SCHEDULE OF FAIR VALUE MEASURED ON RECURRING BASIS

The following table sets forth a summary of the changes in the fair value of Level 3 liabilities that are measured at fair value on a recurring basis during the three months ended March 31, 2024:

 

 

Balance, January 1, 2024 (as restated)  $1,543,953 
Issuance of warrants   2,189,420 
Exercise of warrants   (1,115,334)
Change in fair value of derivative liability   137,319 
Balance, March 31, 2024  $2,755,358 
SCHEDULE OF FAIR VALUE RECURRING BASIS

 

   Fair value measurements at reporting date using: 
   Quoted prices in active markets for identical liabilities (Level 1)   Significant other observable inputs (Level 2)   Significant unobservable inputs (Level 3)   Total Fair Value 
Assets:                    
Marketable securities as of March 31, 2024  $15,261,220   $-   $-   $15,261,220 
Marketable securities as of December 31, 2023  $10,181,618   $-   $-   $10,181,618 
                     
Liabilities:                    
Derivative liabilities as of March 31, 2024  $-   $-   $2,755,358   $2,755,358 
Derivative liabilities as of December 31, 2023 (as restated)  $-   $-   $1,543,953   $1,543,953